BP lowering with perindopril/indapamide an ADVANCE in diabetes

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1604, 2007-01, pp. : 9-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gender influences BP response to perindopril/indapamide

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The ADVANCE Trial: Clarifying the Role of Perindopril/Indapamide Fixed-Dose Combination in the Reduction of Cardiovascular and Renal Events in Patients with Diabetes Mellitus

By Waeber Bernard

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 5, 2009-10 ,pp. : 283-291

Adis International

Access to resources Recommend Favorite

Perindopril/Indapamide: A Viewpoint by Norman M. Kaplan

By Kaplan N.M.

Drugs, Vol. 58, Iss. 2, 1999-08 ,pp. : 303-304

Adis International

Access to resources Recommend Favorite

Perindopril/Indapamide 2/0.625 mg/day: A Review of its Place in the Management of Hypertension

By Matheson A.J. Cheer S.M. Goa K.L.

Drugs, Vol. 61, Iss. 8, 2001-01 ,pp. : 1211-1229

Adis International

Access to resources Recommend Favorite

Intensive glucose and BP lowering ADVANCEs diabetes care

Inpharma, Vol. 1, Iss. 1656, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite